[BLP-25 is designed to target an immune response to the MUC-1 mucin that is shown by > 90% of common solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE